| Quarter | Score |
|---|---|
| 2022-Q1 | 49.8 |
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.2 |
| 2023-Q1 | 50.3 |
| 2023-Q2 | 64.2 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 60.8 |
| 2024-Q2 | 56.7 |
| 2024-Q3 | 57.5 |
| 2024-Q4 | 57.6 |
| 2025-Q1 | 58.5 |
| 2025-Q2 | 37.6 |
| 2025-Q3 | 61.6 |
| 2025-Q4 | 64.0 |
| 2026-Q1 | 61.8 |
| 2026-Q2 | 38.0 |
Active institutional exit or low consensus; avoid or liquidate
No price reference available to measure drift vs fund cost basis
0 of 18 tracked funds hold GMED. Net trimming.
Insufficient data for price analysis
No current holders
Too early to measure — check back next quarter
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|